T Th he e e ef ff fe ec ct t o of f t tr re ea at tm me en nt t o of f a ac cu ut te e l ly ym mp ph ho ob bl la as st ti ic c l le eu uk ke em mi ia a o on n m me ea an n e er ry yt th hr ro oy yt te e v vo ol lu um me e i in n c ch hi il ld dr re en n T Ti ir ra aj je e C Ce el lk ka an n, , N Ni ih ha al l Ö Öz zd de em mi ir r , , Z Ze ek ke er ri iy ya a Material and Method:One hundred-twenty-five children with ALL were included in this retrospective study. The MCV values of the patients (age 1-15 years, 83 boys, 42 girls) at diagnosis, at induction/consolidation chemotherapy and after maintenance treatment were evaluated. Results:The MCV values of the patients at diagnosis, at induction/consolidation chemotherapy and after maintenance treatment were 78,5+3,9 fl; 89,1+6,8 fl and 95,6+3,8 fl, respectively. On follow-up, MCV values were found to decrease with a mean of 1 fl per month after chemotherapy. The results of 15 relapsed patients were compared with results of 110 patients without relapse; there was no statistically significant difference in MCV values ( p>0.05).Conclusions: MCV was not found to be a significant parameter in relation to prognosis and relapse in children with ALL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.